Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

05Mar 2025

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

More
27Feb 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

More

Financial Calendar

12Mar 2025

Barclays Global Healthcare Conference 2025

Add to Calendar
27Feb 2025

Amphastar Fourth Quarter Earnings Call

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.
Youtube